Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-02
1998-09-22
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
435118, 540454, A01N 4376, C12P 1716, C07D26722
Patent
active
058114408
ABSTRACT:
The present invention relates to the novel antitumor antibiotic designated BMS-199687 and to its preparation. The compound is obtained by culturing a new strain of Actinomadura ferruginea. BMS-199687 demonstrates antitumor activity in standard antitumor animal model systems.
REFERENCES:
Biochem. J. 115:1031-1045, 1969.
Bursuker Isia
Chang Li-Ping
Hugill Robert
Mamber Stephen W.
Tsunakawa Mitsuaki
Bristol--Myers Squibb Company
Lilling Herbert J.
Morse David M.
LandOfFree
Antitumor antibiotic BMS-199687 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumor antibiotic BMS-199687, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor antibiotic BMS-199687 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1622079